Stocks and InvestingStocks and Investing
Mon, November 29, 2021
Fri, November 26, 2021
Wed, November 24, 2021
Tue, November 23, 2021
Mon, November 22, 2021

Matthew Harrison Maintained (BMRN) at Hold with Increased Target to $90 on, Nov 22nd, 2021


Published on 2024-10-27 18:45:08 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Hold with Increased Target from $82 to $90 on, Nov 22nd, 2021.

Matthew has made no other calls on BMRN in the last 4 months.



There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Kennen MacKay of "RBC Capital" Maintained at Hold with Increased Target to $88 on, Thursday, July 29th, 2021


This is the rating of the analyst that currently disagrees with Matthew


  • Paul Matteis of "Stifel" Upgraded from Hold to Strong Buy and Increased Target to $96 on, Thursday, September 9th, 2021